• Latest
  • Trending
  • All
  • News
  • Business
  • Lifestyle
Fauci Says He Will Take New Pfizer Vaccine if FDA Approves It

Fauci Says He Will Take New Pfizer Vaccine if FDA Approves It

November 10, 2020

Popular Trump ally Steve Daines bows out of Montana Senate race, gearing up for retirement.

March 5, 2026

Steve Daines, key Trump ally, announces retirement instead of running for Montana Senate seat.

March 5, 2026

Steve Daines, Close Trump Ally, Steps Down from Montana Senate Race and Looks Forward to Retirement.

March 4, 2026

Trump’s top ally Steve Daines announces retirement from Montana Senate race. Join us in bidding farewell!

March 4, 2026

GOP senators clash with Noem during intense hearing over handling of deportation surge

March 4, 2026

FBI spokesperson discredits media’s portrayal of recent firings as damaging to work in Iran. Click here to learn the truth!

March 4, 2026

Online Ridicule: Walz Faces Backlash After GOP Lawmaker Suggests Curious Theory on Kamala Harris VP Pick

March 4, 2026

Republicans Unite Behind Trump as Operation Epic Fury Overcomes Senate Hurdles

March 4, 2026

Justice Jackson leads Supreme Court in delivering unanimous immigration victory to Trump

March 4, 2026

Trump hints at potential game-changing endorsement in Texas to nudge fellow candidate out of runoff.

March 4, 2026

Decrease in Iranian ballistic missile launches observed since launch of Operation Epic Fury.

March 4, 2026

Progressive candidate gracefully bows out of race post viral teasing for ‘disappointing’ loss.

March 4, 2026
  • Trending Topics:    
  • 2024 Election
  • Joe Biden
  • Donald Trump
  • Congress
  • Faith
  • Sports
  • Immigration
Thursday, March 5, 2026
IJR
  • Politics
  • US News
  • Commentary
  • World News
  • Faith
  • Latest Headlines
No Result
View All Result
IJR
No Result
View All Result
Home News

Fauci Says He Will Take New Pfizer Vaccine if FDA Approves It

by Reuters
November 10, 2020 at 2:11 pm
in News
242 10
0
Fauci Says He Will Take New Pfizer Vaccine if FDA Approves It

FILE PHOTO: Anthony Fauci, MD, Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, testifies during a U.S. Senate Senate Health, Education, Labor, and Pensions Committee Hearing to examine COVID-19, focusing on an update on the federal response at the U.S. Capitol Washington, D.C., U.S., September 23, 2020. (Graeme Jennings/Reuters)

491
SHARES
1.4k
VIEWS
Share on FacebookShare on Twitter

U.S. infectious disease expert Anthony Fauci said he will take Pfizer Inc’s new coronavirus vaccine if the Food and Drug Administration approves it and that he has confidence in the company and the government agency.

Asked on MSNBC if he would take the vaccine, Fauci said: “I’m going to look at the data, but I trust Pfizer. I trust the FDA. These are colleagues of mine for decades, the career scientists. If they look at this data, and they say this data is solid, let’s go ahead and approve it, I promise you, I will take the vaccine, and I will recommend that my family take the vaccine.”

(Reporting by Doina Chiacu; Editing by Chizu Nomiyama)

Tags: Anthony FauciCoronavirus Outbreak
Share196Tweet123
Reuters

Reuters

Reuters is an international news organization.

Join Over 6M Subscribers

We’re organizing an online community to elevate trusted voices on all sides so that you can be fully informed.





IJR

    Copyright © 2024 IJR

Trusted Voices On All Sides

  • About Us
  • GDPR Privacy Policy
  • Terms of Service
  • Editorial Standards & Corrections Policy
  • Subscribe to IJR

Follow Us

No Result
View All Result
  • Politics
  • US News
  • Commentary
  • World News
  • Faith
  • Latest Headlines

    Copyright © 2024 IJR

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Thanks for reading IJR

Create your free account or log in to continue reading

Please enter a valid email
Forgot password?

By providing your information, you are entitled to Independent Journal Review`s email news updates free of charge. You also agree to our Privacy Policy and newsletter email usage